Biosimilars And Reference Price Groups In Germany

Are Biosimilars Identical to the Reference Products?

Biosimilars Entry And Price Development In Europe.

In light of the increasing interest in pricing and entry of biosimilars in Europe, this research has found that the market of filgrastim biosimilars is dominated by the entry effect, while that of epoetins is driven by the competition effect. The epoetins market gets saturated relatively faster in terms of number of local competitors, which can be explained by the molecular complexity of that m...

Are Biosimilars Identical to the Reference Products?

are biosimilars identical to the reference products?

0

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany

OBJECTIVES This study examined gastroenterologists' motivation for prescribing biosimilars, assessed their treatment preferences in relation to prescribing behaviour, and explored patient attitudes to biosimilars. METHODS Data were taken from the Adelphi Real World Biosimilars Programme, a real-world, cross-sectional study undertaken in 2015-2016 with German gastroenterologists and patients w...